Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive Rats

Alcalase is the enzyme of choice to release antihypertensive peptides from amaranth proteins, but the hydrolysis conditions have not been optimized yet. Furthermore, in vivo assays are needed to confirm such a hypotensive effect. Our aim was to optimize the hydrolysis of amaranth protein with alcala...

Full description

Bibliographic Details
Main Authors: Giovanni Ramírez-Torres, Noé Ontiveros, Verónica Lopez-Teros, Jesús Aurelio Ibarra-Diarte, Cuauhtémoc Reyes-Moreno, Edith Oliva Cuevas-Rodríguez, Francisco Cabrera-Chávez
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/22/11/1905
_version_ 1811223018650730496
author Giovanni Ramírez-Torres
Noé Ontiveros
Verónica Lopez-Teros
Jesús Aurelio Ibarra-Diarte
Cuauhtémoc Reyes-Moreno
Edith Oliva Cuevas-Rodríguez
Francisco Cabrera-Chávez
author_facet Giovanni Ramírez-Torres
Noé Ontiveros
Verónica Lopez-Teros
Jesús Aurelio Ibarra-Diarte
Cuauhtémoc Reyes-Moreno
Edith Oliva Cuevas-Rodríguez
Francisco Cabrera-Chávez
author_sort Giovanni Ramírez-Torres
collection DOAJ
description Alcalase is the enzyme of choice to release antihypertensive peptides from amaranth proteins, but the hydrolysis conditions have not been optimized yet. Furthermore, in vivo assays are needed to confirm such a hypotensive effect. Our aim was to optimize the hydrolysis of amaranth protein with alcalase and to test in vivo the hypotensive effect of the hydrolysates. A response surface analysis was carried out to optimize the hydrolysis reaction. The response variable was the Angiotensin Converting Enzyme (ACE-I) inhibition. The hydrolysis degree was determined (free alpha-amino groups measurement). The optimized hydrolysate bioavailability was assessed in the sera of mice and the hypotensive effect was assessed in spontaneously hypertensive rats. Control groups were administered captopril or water. The optimized hydrolysis conditions were: pH = 7.01, temperature = 52 °C, enzyme concentration 0.04 mU/mg, and time = 6.16 h. The optimized hydrolysate showed a 93.5% of ACE-I inhibition and a hydrolysis degree of 74.77%. After supplementation, the hydrolysate was bioavailable in mice from 5 to 60 min, and the hypotensive effect started at 4 h in spontaneously hypertensive rats (p < 0.05 vs. water group). This effect was similar to the captopril hypotensive effect for the next 3 h (p > 0.05). The use of amaranth-optimized hydrolysates as hypotensive supplements or ingredient for functional foods seems feasible.
first_indexed 2024-04-12T08:24:46Z
format Article
id doaj.art-b8fad4d1b26f4c1c853787043bc13345
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-12T08:24:46Z
publishDate 2017-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-b8fad4d1b26f4c1c853787043bc133452022-12-22T03:40:26ZengMDPI AGMolecules1420-30492017-11-012211190510.3390/molecules22111905molecules22111905Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive RatsGiovanni Ramírez-Torres0Noé Ontiveros1Verónica Lopez-Teros2Jesús Aurelio Ibarra-Diarte3Cuauhtémoc Reyes-Moreno4Edith Oliva Cuevas-Rodríguez5Francisco Cabrera-Chávez6Nutritional Sciences, Department of Chemical and Biological Sciences, University of Sonora, Hermosillo, Sonora 83000, MexicoNutrition Sciences Academic Unit, University of Sinaloa, Culiacán, Sinaloa 80019, MexicoNutritional Sciences, Department of Chemical and Biological Sciences, University of Sonora, Hermosillo, Sonora 83000, MexicoNutrition Sciences Academic Unit, University of Sinaloa, Culiacán, Sinaloa 80019, MexicoFaculty of Chemical and Biological Sciences, University of Sinaloa, Culiacán, Sinaloa 80199, MexicoFaculty of Chemical and Biological Sciences, University of Sinaloa, Culiacán, Sinaloa 80199, MexicoFaculty of Physical Education and Sport, University of Sinaloa, Culiacán, Sinaloa 80019, MexicoAlcalase is the enzyme of choice to release antihypertensive peptides from amaranth proteins, but the hydrolysis conditions have not been optimized yet. Furthermore, in vivo assays are needed to confirm such a hypotensive effect. Our aim was to optimize the hydrolysis of amaranth protein with alcalase and to test in vivo the hypotensive effect of the hydrolysates. A response surface analysis was carried out to optimize the hydrolysis reaction. The response variable was the Angiotensin Converting Enzyme (ACE-I) inhibition. The hydrolysis degree was determined (free alpha-amino groups measurement). The optimized hydrolysate bioavailability was assessed in the sera of mice and the hypotensive effect was assessed in spontaneously hypertensive rats. Control groups were administered captopril or water. The optimized hydrolysis conditions were: pH = 7.01, temperature = 52 °C, enzyme concentration 0.04 mU/mg, and time = 6.16 h. The optimized hydrolysate showed a 93.5% of ACE-I inhibition and a hydrolysis degree of 74.77%. After supplementation, the hydrolysate was bioavailable in mice from 5 to 60 min, and the hypotensive effect started at 4 h in spontaneously hypertensive rats (p < 0.05 vs. water group). This effect was similar to the captopril hypotensive effect for the next 3 h (p > 0.05). The use of amaranth-optimized hydrolysates as hypotensive supplements or ingredient for functional foods seems feasible.https://www.mdpi.com/1420-3049/22/11/1905antihypertensive peptidesamaranthACE-I inhibition
spellingShingle Giovanni Ramírez-Torres
Noé Ontiveros
Verónica Lopez-Teros
Jesús Aurelio Ibarra-Diarte
Cuauhtémoc Reyes-Moreno
Edith Oliva Cuevas-Rodríguez
Francisco Cabrera-Chávez
Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive Rats
Molecules
antihypertensive peptides
amaranth
ACE-I inhibition
title Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive Rats
title_full Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive Rats
title_fullStr Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive Rats
title_full_unstemmed Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive Rats
title_short Amaranth Protein Hydrolysates Efficiently Reduce Systolic Blood Pressure in Spontaneously Hypertensive Rats
title_sort amaranth protein hydrolysates efficiently reduce systolic blood pressure in spontaneously hypertensive rats
topic antihypertensive peptides
amaranth
ACE-I inhibition
url https://www.mdpi.com/1420-3049/22/11/1905
work_keys_str_mv AT giovanniramireztorres amaranthproteinhydrolysatesefficientlyreducesystolicbloodpressureinspontaneouslyhypertensiverats
AT noeontiveros amaranthproteinhydrolysatesefficientlyreducesystolicbloodpressureinspontaneouslyhypertensiverats
AT veronicalopezteros amaranthproteinhydrolysatesefficientlyreducesystolicbloodpressureinspontaneouslyhypertensiverats
AT jesusaurelioibarradiarte amaranthproteinhydrolysatesefficientlyreducesystolicbloodpressureinspontaneouslyhypertensiverats
AT cuauhtemocreyesmoreno amaranthproteinhydrolysatesefficientlyreducesystolicbloodpressureinspontaneouslyhypertensiverats
AT editholivacuevasrodriguez amaranthproteinhydrolysatesefficientlyreducesystolicbloodpressureinspontaneouslyhypertensiverats
AT franciscocabrerachavez amaranthproteinhydrolysatesefficientlyreducesystolicbloodpressureinspontaneouslyhypertensiverats